Your browser doesn't support javascript.
loading
Mitochondria-lysosome-related organelles mediate mitochondrial clearance during cellular dedifferentiation.
Ma, Xiaowen; Manley, Sharon; Qian, Hui; Li, Yuan; Zhang, Chen; Li, Kevin; Ding, Benjamin; Guo, Fengli; Chen, Allen; Zhang, Xing; Liu, Meilian; Hao, Meihua; Kugler, Benjamin; Morris, E Matthew; Thyfault, John; Yang, Ling; Sesaki, Hiromi; Ni, Hong-Min; McBride, Heidi; Ding, Wen-Xing.
Affiliation
  • Ma X; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Manley S; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Qian H; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Li Y; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Zhang C; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Li K; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Ding B; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Guo F; Stowers Institute for Medical Research, Kansas City, MO, USA; Department of Pathology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Chen A; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Zhang X; Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
  • Liu M; Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
  • Hao M; Department of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
  • Kugler B; Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Morris EM; Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Thyfault J; Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Yang L; Department of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
  • Sesaki H; Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Ni HM; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • McBride H; Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Ding WX; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: wxding@kumc.edu.
Cell Rep ; 42(10): 113291, 2023 10 31.
Article in En | MEDLINE | ID: mdl-37862166
ABSTRACT
Dysfunctional mitochondria are removed via multiple pathways, such as mitophagy, a selective autophagy process. Here, we identify an intracellular hybrid mitochondria-lysosome organelle (termed the mitochondria-lysosome-related organelle [MLRO]), which regulates mitochondrial homeostasis independent of canonical mitophagy during hepatocyte dedifferentiation. The MLRO is an electron-dense organelle that has either a single or double membrane with both mitochondria and lysosome markers. Mechanistically, the MLRO is likely formed from the fusion of mitochondria-derived vesicles (MDVs) with lysosomes through a PARKIN-, ATG5-, and DRP1-independent process, which is negatively regulated by transcription factor EB (TFEB) and associated with mitochondrial protein degradation and hepatocyte dedifferentiation. The MLRO, which is galectin-3 positive, is reminiscent of damaged lysosome and could be cleared by overexpression of TFEB, resulting in attenuation of hepatocyte dedifferentiation. Together, results from this study suggest that the MLRO may act as an alternative mechanism for mitochondrial quality control independent of canonical autophagy/mitophagy involved in cell dedifferentiation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organelles / Mitochondria Language: En Journal: Cell Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organelles / Mitochondria Language: En Journal: Cell Rep Year: 2023 Document type: Article